Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Paola A. Guerrero

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7345-1246; OpenAlex author ID A5062779886, A5067241648. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
94
Papers, trials and grants by year

2019: 3 papers · 2020: 1 paper · 2021: 3 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 16

  1. CDK8 remodels the tumor microenvironment and promotes resistance to KRAS G12D inhibitors and daraxonrasib in PDAC. Co-author DOI 10.1038/s44318-026-00854-5↗
  2. Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer Co-author DOI 10.64898/2026.03.03.709150↗
  3. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Co-author DOI 10.1038/s41586-025-08927-x↗
  4. An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adt5511↗
  5. Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0177↗
  6. KRAS G12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells. Co-author DOI 10.1016/j.ccell.2023.07.002↗
  7. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an ea… Co-author DOI 10.1101/2023.08.14.553002↗
  8. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Co-author DOI 10.1038/s41467-022-31376-3↗
  9. Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.12.273↗
  10. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Last author DOI 10.1038/s41416-021-01350-9↗
  11. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Last author DOI 10.1158/1078-0432.ccr-20-2667↗
  12. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Last author DOI 10.1158/1078-0432.ccr-20-3925↗
  13. Diversity Across the Pancreatic Ductal Adenocarcinoma Disease Spectrum Revealed by Network-Anchored Functional Genomics Co-author DOI 10.1101/2020.09.17.302034↗
  14. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2018.09.022↗
  15. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progre… Co-author DOI 10.1158/1078-0432.ccr-18-1955↗
  16. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Co-author DOI 10.7554/elife.50663↗

Closest collaborators

The 25 strongest of 94 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 14 shared papers, 2019–2026 · strength 1.67
  2. Vincent Bernard · 8 shared papers, 2019–2026 · strength 0.97
  3. Alexander Semaan · 7 shared papers, 2019–2025 · strength 0.77
  4. Timothy Paul Heffernan · 4 shared papers, 2020–2026 · strength 0.57
  5. Jaewon James Lee · 5 shared papers, 2020–2022 · strength 0.54
  6. Kathleen M. McAndrews · 3 shared papers, 2023–2026 · strength 0.48
  7. Krishnan K. Mahadevan · 3 shared papers, 2023–2026 · strength 0.48
  8. Raghu Kalluri · 3 shared papers, 2023–2026 · strength 0.48
  9. Maria E. Monberg · 4 shared papers, 2021–2022 · strength 0.48
  10. Fredrik I. Thege · 3 shared papers, 2023–2025 · strength 0.46
  11. Michael P. Kim · 4 shared papers, 2019–2023 · strength 0.42
  12. Matthew H. G. Katz · 4 shared papers, 2019–2022 · strength 0.38
  13. Benson Chellakkan Selvanesan · 2 shared papers, 2025 · strength 0.33
  14. Jimin Min · 2 shared papers, 2023–2025 · strength 0.31
  15. Cullen M. Taniguchi · 3 shared papers, 2019–2021 · strength 0.26
  16. Nabiollah Kamyabi · 3 shared papers, 2019–2021 · strength 0.25
  17. Hector A. Alvarez · 3 shared papers, 2019–2021 · strength 0.25
  18. Dimitrios N. Sidiropoulos · 1 shared paper, 2026 · strength 0.22
  19. Elana Judith Fertig · 1 shared paper, 2026 · strength 0.22
  20. Pei-Hsun Wu · 1 shared paper, 2026 · strength 0.22
  21. Luciane Tsukamoto Kagohara · 1 shared paper, 2026 · strength 0.22
  22. André Forjaz · 1 shared paper, 2026 · strength 0.22
  23. Laura DeLong Wood · 1 shared paper, 2026 · strength 0.22
  24. Vincent Bernard Pagan · 1 shared paper, 2026 · strength 0.22
  25. Won Jin Ho · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.